Report Description
The global COVID-19 sample collection kits market size was valued at USD 12.9 billion in 2020 and is projected to expand at a CAGR of 3.6% during the forecast period, 2021-2028. The growth of the market is attributed to the introduction of standard procedures with the guidance of proper specimen collection of COVID-19 patients across regions.
The COVID-19 is a highly infectious disease caused by a virus called the severe acute respiratory syndrome or the SARS coronavirus. This disease was initially identified to be originated from Wuhan City, located at the Hubei Province, China as an outbreak reported of respiratory illness. The first preliminary reports about this coronavirus were submitted to World Health Organization (WHO) on December 31st, 2019. One month later, WHO announced that the COVID-19 outbreak as a pandemic and a global health emergency for the population worldwide. The last global pandemic that the world witnessed was the H1N1 influenza back in 2009.
Symptoms of the COVID-19 ranged from common cold to life threatening diseases such as lack of breadth and lower heart rate. Transmission of the COVID-19 virus occurs when people were exposed to the airborne particles which were exhaled by an infectious person. This risk of the infection gets higher when people come in close contact such as shaking hands or hugging. As a consequence, this pandemic has caused both economic and social disruptions across the globe as governments had to impose movement restriction and complete shutdown of the manufacturing industries to curb the virus spread. Schools and colleges were closed indefinitely while several companies were forced to operate at half staffs or closed down.
Market Trends, Drivers, Restraints, and Opportunities
- The primary driver for the COVID-19 sample collection kits market is the introduction of the improved sampling method and effective diagnosis of the SARS infection.
- Rising collaborations with their regional suppliers and authorities from major stakeholders for the production of sample collection kits is a key driver boosting the market.
- Huge funding from government and administrative bodies encouraging the development and faster supply of kits to meet the needs of their respective regions and countries. This is expected to fuel the market expansion. .
- The second wave of the COVID-19 pandemic has caused more deaths and is seemingly more dangerous than the first wave. This further boosts the demand for sample collection kits from countries across regions.
- Restriction in the supply for kits due to uneasy approval process from government and regulatory bodies is a key challenge that can hamper the market growth.
Scope of COVID-19 Sample Collection Kits Market Report
The report on the global COVID-19 sample collection kits market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attribute
|
Details
|
Report Title
|
COVID-19 Sample Collection Kits Market – Global Industry Analysis, Growth, Share, Size, Trends and Forecast
|
Base Year
|
2020
|
Historic Data
|
2018-2019
|
Forecast Period
|
2021-2028
|
Segmentation
|
Products (Swabs [Nasopharyngeal Swabs, Oropharyngeal Swabs, and Others], Viral Transport Media, Blood Collection Kits, and Other Consumables), Application Areas (Diagnostics and Research), and Sites of Collection (Hospitals & Clinics and Home Test)
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
Puritan Medical Products; COPAN Diagnostics; Becton, Dickinson and Company; Thermo Fisher Scientific, Inc; Laboratory Corporation of American Holdings; Lucence Diagnostics Pte Ltd; Hardy Diagnostics; Trinity Biotech; Quidel Corporation; Quest Diagnostics; Danahar Corporation; Vitagene Inc; Formlabs; HiMedia Laboratories; VIRCELL S.L; US Cotton; and Cepheid
|
Global COVID-19 Sample Collection Kits Market Segment Insights
Swabs segment to constitute a key market share
On the basis of products, the COVID-19 sample collection kits market is segmented into swabs, viral transport media, blood collection kits, and other consumables. The swabs segment is further divided into nasopharyngeal swabs, oropharyngeal swabs, and others. Of all these segments, the swabs segment held a leading share of the market representing above 42% in 2020 and is expected to constitute a key market share in the coming years. This segment growth is attributed primarily to the approval of a significant number of COVID-19 diagnostic products with the use of nasopharyngeal swabs. Other samples can be used from the respiratory tract which cannot be collected by the nasopharyngeal swabs.
In these scenarios, the medical team relies on the oropharyngeal swabs. Rising investment from key market players to improve their distribution and supply chain processes is another key factor driving the segment growth. For instance, in November 2020, Puritan Medical Products received funds worth USD 11.8 million for the expansion of their swab manufacturing capabilities. Additional funds were also organized by the Health Care Enhancement Act and Paycheck Protection Program.
Diagnostics segment is anticipated to account for a large revenue share
On the basis of application areas, the market is bifurcated into diagnostics and research. The diagnostics segment held more than 65.9% of the market in 2020 and is projected to account for a large revenue share of the market in the coming years. This is contributed mainly because of the continuous approvals by the regulatory bodies to conduct diagnostic tests. As of December 2nd, 2020, the US approved 1299 tests, all conducted by the diagnostic applications.
The advanced use of swabs required for the disease diagnosis acts as a major driving factor for the segment growth. Innovations and advancement in the diagnostics segment are significantly higher than that of the research segment, which is more from a theoretical standpoint. On the other hand, the research segment is rapidly increasing its market share owing to the wide research & development activities in laboratories and universities, but the patent approval and other processes would be time consuming. However, the increase in funding towards this segment can be a key driver for the segment expansion.
Hospitals & clinics segments estimated to hold more than 90% of the market
On the basis of sites of collection, the COVID-19 sampling collection kits market is bifurcated into hospitals & clinics and home test. The hospitals & clinics segment held a major share of the market accounting for more than 90% of the global market in 2020 due to the exponential rise in number of hospitalizations with respect to the COVID-19 pandemic.
Meanwhile, the home tests are expected to register a moderate growth rate as the test settings are not fully developed due to lack of infrastructures. People also felt that hospitals, with their expertise, were a safer option against the coronavirus. With the pandemic started to increase daily, hospitals start adopting various devices and technology to expand and innovate their testing capabilities. However, new methods such as the “COVID-19 Immunity Profile”, an application introduced by Mybiopassport allowed people to run their blood collection tests at home.
North America dominates the COVID-19 sampling collection kits market
In terms of regions, the market is classified as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to constitute nearly 35% of the global COVID-19 sampling collection kits market in the coming years. The USA is currently one of the most affected countries in the world with the highest number of COVID-19 cases and death. As per the US Government report, the country has already conducted over 210 million COVID-19 tests, which is considered to be one of the most single handedly tests any country has performed in the world.
Moreover, the facilities in USA are normally believed that it can process roughly 600,000 tests per day. In early March, 2021, the US Department of Defense offered a USD 52 million contract with Puritan Medical Products to innovate better supply chains of the testing kits and others devices.
On the other hand, Europe is projected to hold a large market share in the coming years owing to increasing investment from governments across the region to increase more hospitals and healthcare centers exclusively for the COVID-19 pandemic. Meanwhile, Asia Pacific is expected to register a high CAGR during the forecast period owing to the increasing number of COVID-19 patients. Countries such as India are in constant need for testing kits due to surge in COVID-19 cases due to Second wave of the pandemic.
Segments
The global COVID-19 sampling collection kits market has been segmented in terms of
Products
- Swabs
- Nasopharyngeal Swabs
- Oropharyngeal Swabs
- Others
- Viral Transport Media
- Blood Collection Kits
- Other Consumables
Application Areas
Sites of Collection
- Hospitals & Clinics
- Home Test
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Puritan Medical Products
- COPAN Diagnostics
- Becton, Dickinson and Company
- Thermo Fisher Scientific, Inc
- Laboratory Corporation of American Holding
- Lucence Diagnostics Pte Ltd
- Hardy Diagnostics
- Trinity Biotech
- Quidel Corporation
- Quest Diagnostics
- Danahar Corporation
- Vitagene Inc
- Formlabs
- HiMedia Laboratories
- VIRCELL S.L
- US Cotton
- Cepheid
Competitive Landscape
Key players of the COVID-19 sampling collection kits market are Puritan Medical Products; COPAN Diagnostics; Becton, Dickinson and Company; Thermo Fisher Scientific, Inc; Laboratory Corporation of American Holdings; Lucence Diagnostics Pte Ltd; Hardy Diagnostics; Trinity Biotech; Quidel Corporation; Quest Diagnostics; Danahar Corporation; Vitagene Inc; Formlabs; HiMedia Laboratories; VIRCELL S.L; US Cotton; and Cepheid.
A significant number of well-established players have focused to innovate their products at a quicker rate. This made the market competition much more intense than usual amid government initiatives to allocate a certain expenditure to COVID-19 vaccinations and research studies. These companies increased their capacity of production of swabs with respect to their patients’ demands. Every company now focuses on the constant efforts to offer easy product distribution and transportation to all their patients besides implementing new technology.
Table Of Content
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. COVID-19 Sample Collection Kits Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. COVID-19 Sample Collection Kits Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. COVID-19 Sample Collection Kits Market - Supply Chain
4.5. Global COVID-19 Sample Collection Kits Market Forecast
4.5.1. COVID-19 Sample Collection Kits Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. COVID-19 Sample Collection Kits Market Size (000’ Units) and Y-o-Y Growth
4.5.3. COVID-19 Sample Collection Kits Market Absolute $ Opportunity
5. Global COVID-19 Sample Collection Kits Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. COVID-19 Sample Collection Kits Market Size and Volume Forecast by Types
5.3.1. Swabs
5.3.2.
Viral Transport Media
5.3.3.
Blood Collection Kits
5.3.4.
Other Consumables
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global COVID-19 Sample Collection Kits Market Analysis and Forecast by Applications
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Applications
6.2.2. Y-o-Y Growth Projections by Applications
6.3. COVID-19 Sample Collection Kits Market Size and Volume Forecast by Applications
6.3.1. Diagnostic
6.3.2.
Research
6.4. Absolute $ Opportunity Assessment by Applications
6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global COVID-19 Sample Collection Kits Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. COVID-19 Sample Collection Kits Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global COVID-19 Sample Collection Kits Demand Share Forecast, 2019-2026
8. North America COVID-19 Sample Collection Kits Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America COVID-19 Sample Collection Kits Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America COVID-19 Sample Collection Kits Market Size and Volume Forecast by Types
8.4.1. Swabs
8.4.2.
Viral Transport Media
8.4.3.
Blood Collection Kits
8.4.4.
Other Consumables
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America COVID-19 Sample Collection Kits Market Size and Volume Forecast by Applications
8.7.1. Diagnostic
8.7.2.
Research
8.8. Basis Point Share (BPS) Analysis by Applications
8.9. Y-o-Y Growth Projections by Applications
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America COVID-19 Sample Collection Kits Demand Share Forecast, 2019-2026
9. Latin America COVID-19 Sample Collection Kits Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America COVID-19 Sample Collection Kits Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America COVID-19 Sample Collection Kits Market Size and Volume Forecast by Types
9.4.1. Swabs
9.4.2.
Viral Transport Media
9.4.3.
Blood Collection Kits
9.4.4.
Other Consumables
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America COVID-19 Sample Collection Kits Market Size and Volume Forecast by Applications
9.7.1. Diagnostic
9.7.2.
Research
9.8. Basis Point Share (BPS) Analysis by Applications
9.9. Y-o-Y Growth Projections by Applications
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America COVID-19 Sample Collection Kits Demand Share Forecast, 2019-2026
10. Europe COVID-19 Sample Collection Kits Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe COVID-19 Sample Collection Kits Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe COVID-19 Sample Collection Kits Market Size and Volume Forecast by Types
10.4.1. Swabs
10.4.2.
Viral Transport Media
10.4.3.
Blood Collection Kits
10.4.4.
Other Consumables
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe COVID-19 Sample Collection Kits Market Size and Volume Forecast by Applications
10.7.1. Diagnostic
10.7.2.
Research
10.8. Basis Point Share (BPS) Analysis by Applications
10.9. Y-o-Y Growth Projections by Applications
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe COVID-19 Sample Collection Kits Demand Share Forecast, 2019-2026
11. Asia Pacific COVID-19 Sample Collection Kits Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific COVID-19 Sample Collection Kits Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific COVID-19 Sample Collection Kits Market Size and Volume Forecast by Types
11.4.1. Swabs
11.4.2.
Viral Transport Media
11.4.3.
Blood Collection Kits
11.4.4.
Other Consumables
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific COVID-19 Sample Collection Kits Market Size and Volume Forecast by Applications
11.7.1. Diagnostic
11.7.2.
Research
11.8. Basis Point Share (BPS) Analysis by Applications
11.9. Y-o-Y Growth Projections by Applications
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific COVID-19 Sample Collection Kits Demand Share Forecast, 2019-2026
12. Middle East & Africa COVID-19 Sample Collection Kits Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa COVID-19 Sample Collection Kits Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa COVID-19 Sample Collection Kits Market Size and Volume Forecast by Types
12.4.1. Swabs
12.4.2.
Viral Transport Media
12.4.3.
Blood Collection Kits
12.4.4.
Other Consumables
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa COVID-19 Sample Collection Kits Market Size and Volume Forecast by Applications
12.7.1. Diagnostic
12.7.2.
Research
12.8. Basis Point Share (BPS) Analysis by Applications
12.9. Y-o-Y Growth Projections by Applications
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa COVID-19 Sample Collection Kits Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global COVID-19 Sample Collection Kits Market: Market Share Analysis
13.2. COVID-19 Sample Collection Kits Distributors and Customers
13.3. COVID-19 Sample Collection Kits Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Puritan Medical Products
13.4.2.
COPAN Diagnostics
13.4.3.
Becton, Dickinson and Company
13.4.4.
Thermo Fisher Scientific, Inc
13.4.5.
Laboratory Corporation of American Holding
13.4.6.
Lucence Diagnostics Pte Ltd
13.4.7.
Hardy Diagnostics